Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer

Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer

Background. Neoadjuvant chemotherapy (NACT) is an important stage in the treatment of patients with breast cancer. Positron emission tomography/computed tomography (PET/СT) with fluorodeoxyglucose labeled with 18F (18F-FDG) is widely used as an effective method of metabolic tumor imaging at the stag...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Chanchikova, E. A. Karlova, A. S. Savelyeva, O. A. Silkina, V. I. Chernov, R. V. Zelchan, O. D. Bragina, A. A. Medvedeva
Format:	Article
Language:	Russian
Published:	ABV-press 2021-01-01
Series:	Опухоли женской репродуктивной системы
Subjects:	breast cancer positron emission tomography neoadjuvant chemotherapy morphological response prognosis
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/762
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01)

Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy
by: Mark Farrugia, et al.
Published: (2018-10-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

DIFFERENTIAL DIAGNOSIS OF BRAIN GLIOMAS BY POSITRON EMISSION TOMOGRAPHY USING VARIOUS RADIOPHARMACEUTICALS
by: N. A. Kostenikov, et al.
Published: (2016-02-01)

Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01)

Positron Emission Tomography Imaging in Sarcoidosis
by: Beth Vettiyil, et al.
Published: (2013-07-01)

The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas
by: N. G. Chanchikova, et al.
Published: (2021-07-01)

Tumor volume delineation: A pilot study comparing a digital positron-emission tomography prototype with an analog positron-emission tomography system
by: Nghi C. Nguyen, et al.
Published: (2019-01-01)

Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

Magnetic resonance imaging in evaluation of efficiency of neoadjuvant chemotherapy of breast cancer
by: A. V. Komyahov, et al.
Published: (2015-12-01)

Potential Requirement of Positron Emission Tomography Apparatuses in Asia and Latin America Including Mexico
by: Naoyuki Watanabe, et al.
Published: (2013-01-01)

Efficacy of dose-intensive platinum-containing neoadjuvant chemotherapy in the combination treatment for locally advanced cervical cancer
by: O. A. Smirnova, et al.
Published: (2019-02-01)

Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix
by: Hyerim Eum, et al.
Published: (2024-07-01)

STAGE IB2–IIIB CERVICAL CANCER: NEOADJUVANT CHEMOTHERAPY, RADICAL SURGERY AND PATIENT SURVIVAL
by: D. L. Ovodenko, et al.
Published: (2021-06-01)

Prediction of response to neoadjuvant chemotherapy in patients with muscle-invasive urothelial bladder cancer: role of immune-related gene expression
by: Hadeer Mahmoud, et al.
Published: (2025-07-01)

Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
by: Lixi Li, et al.
Published: (2025-05-01)

CT-based quantification of spatiotemporal heterogeneity for predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
by: Wenjun Hu, et al.
Published: (2025-07-01)

Efficacy of neoadjuvant chemotherapy with docetaxel and cisplatin in patients with squamous cell carcinoma of the oral cavity at high risk of progression
by: S. I. Kutukova, et al.
Published: (2025-07-01)

Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2022-03-01)

Using positron-emission tomography–computed tomography for predicting radiotherapy-induced tumor regression in carcinoma esophagus in an Indian population
by: Sankalp Singh, et al.
Published: (2019-10-01)

Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
by: Poonam Joshi, et al.
Published: (2015-01-01)

Case of needle tract seeding during preoperative neoadjuvant chemotherapy for resectable pancreatic cancer
by: Kei Yane, et al.
Published: (2023-04-01)

Dynamics of level of the tumor-associated marker SCCA in neoadjuvant superselective intra-arterial chemotherapy in patients with cervical squamous cell carcinoma
by: N. S. Sergeeva, et al.
Published: (2023-05-01)

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy
by: Gemma Rossi, et al.
Published: (2023-04-01)

Utility of positron emission tomography–computed tomography in the evaluation of fever of unknown origin in a resource-limited tropical nation
by: Sohini Das, et al.
Published: (2021-07-01)

The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer
by: Jonas Busk Holm, et al.
Published: (2025-07-01)

The predictive role of PD-L1 expression and CD8 + TIL levels in determining the neoadjuvant chemotherapy response in advanced ovarian cancer
by: T. Aliyeva, et al.
Published: (2024-11-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
by: Emine Yıldırım, et al.
Published: (2022-01-01)

Multiple scalp metastases from pulmonary adenocarcinoma seen on fluorodeoxyglucose positron-emission tomography/computed tomography
by: Abderrahim Doudouh, et al.
Published: (2020-01-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of suspected paraneoplastic syndromes: A retrospective analysis
by: Richard Bresler, et al.
Published: (2020-04-01)

Correlation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography related parameters with the degree of proliferation in lung adenocarcinoma
by: Jian-gong Shi, et al.
Published: (2025-07-01)

Evaluating cell-free DNA integrity index as a non-invasive biomarker for neoadjuvant chemotherapy in colorectal cancer patients
by: Takuma Iwai, et al.
Published: (2025-07-01)

Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer
by: Meritxell Pérez, et al.
Published: (2025-03-01)

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)

Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging
by: Karin Knesaurek, et al.
Published: (2018-01-01)